Replies to post #785 on Bioxytran Inc (BIXT)

[Ecomike]

This is the kind of news feed you only on major $$$$ Nasdaq Bio-tech drug stocks.

$BIXT

New Research on Bioxytran, Inc. (BIXT-OTCBB)

August 25, 2022 at 8:46 PM

An Executive Informational Overview (EIO) is now available on Bioxytran, Inc., a clinical stage pharmaceutical company developing therapeutics in two areas: (1) glycovirology and anti-viral therapeutics; and (2) hypoxic conditions, necrosis, and degenerative diseases. The 70-page report details the Company's business, its strategy, market opportunities, competition, financials, risks, and more. It is available for download below.

More here:

http://www.crystalra.com/blog/bioxytran-0-0-0-0-0-0?utm_campaign=Bioxytran

Here is peak at page 1